Search research articles
Contact Us
Filters
Showing results (301-310 of 458) with videos related to
Page
of 46
Sort By:
The Lancet. Infectious Diseases
|
June 6, 2013
Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries
Angela Loyse, Harry Thangaraj, Philippa Easterbrook, et al.
Journal of the International AIDS Society
|
January 23, 2025
A global review of national guidelines of post-exposure prophylaxis for the prevention of HIV
Marcus Maisano, Daniel Tran, Virginia Macdonald, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 8, 2018
CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis
Nathan Ford, Zara Shubber, Joseph N Jarvis, et al.
AIDS (London, England)
|
December 11, 2014
Adherence to HIV postexposure prophylaxis: a systematic review and meta-analysis
Nathan Ford, Cadi Irvine, Zara Shubber, et al.
Journal of the International AIDS Society
|
December 4, 2016
Use of peers to improve adherence to antiretroviral therapy: a global network meta-analysis
Steve Kanters, Jay Jh Park, Keith Chan, et al.
Tropical Medicine & International Health : TM & IH
|
October 4, 2016
Antiretroviral therapy status among people who died of AIDS-related causes from 2009 to 2013 in Brazil: a population-based study
Marcelo Araújo de Freitas, Angélica Espinosa Miranda, Ana Roberta Pati Pascom, et al.
The Lancet. Infectious Diseases
|
July 4, 2020
Integration of fungal diseases into health systems in Latin America
Juan Luis Rodriguez Tudela, Donald C Cole, Giovanni Ravasi, et al.
AIDS (London, England)
|
May 11, 2018
The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries: what are the issues?
Marco Vitoria, Andrew Hill, Nathan Ford, et al.
Medicine
|
June 23, 2026
Vaccine effectiveness against COVID-19 in-hospital mortality in people living with HIV across SARS-CoV-2 variant waves: Analyses of data from the WHO Global Clinical Platform
Seth Inzaule, Ronaldo Silva, Nathan Ford, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
September 10, 2010
Treatment interruption in a primary care antiretroviral therapy program in South Africa: cohort analysis of trends and risk factors
Katharina Kranzer, James J Lewis, Nathan Ford, et al.
Page
of 46
Search research articles
Search
Showing results (301-310 of 458) with videos related to
Sort By:
Page
of 46
The Lancet. Infectious Diseases
|
June 6, 2013
Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries
Angela Loyse, Harry Thangaraj, Philippa Easterbrook, et al.
Journal of the International AIDS Society
|
January 23, 2025
A global review of national guidelines of post-exposure prophylaxis for the prevention of HIV
Marcus Maisano, Daniel Tran, Virginia Macdonald, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 8, 2018
CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis
Nathan Ford, Zara Shubber, Joseph N Jarvis, et al.
AIDS (London, England)
|
December 11, 2014
Adherence to HIV postexposure prophylaxis: a systematic review and meta-analysis
Nathan Ford, Cadi Irvine, Zara Shubber, et al.
Journal of the International AIDS Society
|
December 4, 2016
Use of peers to improve adherence to antiretroviral therapy: a global network meta-analysis
Steve Kanters, Jay Jh Park, Keith Chan, et al.
Tropical Medicine & International Health : TM & IH
|
October 4, 2016
Antiretroviral therapy status among people who died of AIDS-related causes from 2009 to 2013 in Brazil: a population-based study
Marcelo Araújo de Freitas, Angélica Espinosa Miranda, Ana Roberta Pati Pascom, et al.
The Lancet. Infectious Diseases
|
July 4, 2020
Integration of fungal diseases into health systems in Latin America
Juan Luis Rodriguez Tudela, Donald C Cole, Giovanni Ravasi, et al.
AIDS (London, England)
|
May 11, 2018
The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries: what are the issues?
Marco Vitoria, Andrew Hill, Nathan Ford, et al.
Medicine
|
June 23, 2026
Vaccine effectiveness against COVID-19 in-hospital mortality in people living with HIV across SARS-CoV-2 variant waves: Analyses of data from the WHO Global Clinical Platform
Seth Inzaule, Ronaldo Silva, Nathan Ford, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
September 10, 2010
Treatment interruption in a primary care antiretroviral therapy program in South Africa: cohort analysis of trends and risk factors
Katharina Kranzer, James J Lewis, Nathan Ford, et al.
Page
of 46